Dualsystems
Publication and more
We identify targets / off-targets of your ligand
If you want to get support for your project
LRC-TriCEPS customers worldwide
Over 200 satisfied customers from 28 countries.
LRC-TriCEPS publications worldwide
Contact form
Please fill out all mandatory (*) fields.
Footer
Social Media
Dualsystems closes Series C Financing Round
Dualsystems Biotech has closed a Series C financing round with support from existing and new investors to implement and drive forward its new business strategy in mass spectrometry based protein interaction discovery.
Dualsystems Biotech sells its yeast two-hybrid (Y2H) activities to Hybrigenics
Dualsystems Biotech is driving its business activities towards new technologies and builds up new strengths in the field of protein interaction discovery.
Licensing Agreement with ETH Zurich on LRC technoloy
Dualsystems Biotech closes Licensing Agreement with ETH Zurich on Ligand Receptor Capture (LRC) technology Dualsystems Biotech has licensed an innovative technology to discover cell-surface receptors for a vast range of ligands of interest. LRC is centered around an innovative trifunctional chemoproteomic reagent named TriCEPS, which enables the unbiased identification of cell surface receptors for many…